Key result
Bioprosthetic heart valves provide effective treatment for valvular heart disease without the need for anticoagulation, but their long-term durability remains limited by age-dependent structural valve degeneration and immune-mediated calcification.
Why the study?
Despite various interventions, an exemplary prosthetic heart valve replacement mimicking normal native heart valve characteristics does not exist.
Current bioprosthetic valves are limited by structural valve degeneration linked to immune responses against xenogeneic antigens, highlighting the need for regenerative tissue-engineered heart valves.
Answers are grounded in this paper and cite their sources.
Bioprosthetic valve durability is limited by degeneration; leaves open regenerative tissue-engineered designs for improved longevity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kan Yan Chloe Li (2019) conducted a review in Valvular heart disease. Bioprosthetic heart valves vs. Mechanical heart valves was evaluated. Bioprosthetic heart valves provide effective treatment for valvular heart disease without the need for anticoagulation, but their long-term durability remains limited by age-dependent structural valve degeneration and immune-mediated calcification.
Synapse has enriched 10 related papers. Consider them for comparative context: